Sinead Cuffe1, Natasha B Leighl. Show Affiliations » 1. Department of Medical Oncology and Hematology of the University Health Network, Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada.
Abstract
Entities: Disease Gene
Mesh： See more » Antineoplastic Agents/therapeutic useCarcinoma, Non-Small-Cell Lung/drug therapyCarcinoma, Non-Small-Cell Lung/metabolismClinical Trials as TopicHumansLung Neoplasms/drug therapyLung Neoplasms/metabolismPhosphatidylinositol 3-Kinase/metabolismPhosphoinositide-3 Kinase InhibitorsProto-Oncogene Proteins c-akt/antagonists & inhibitorsProto-Oncogene Proteins c-akt/metabolismTOR Serine-Threonine Kinases/antagonists & inhibitorsTOR Serine-Threonine Kinases/metabolism
Substances： See more » Antineoplastic AgentsPhosphoinositide-3 Kinase InhibitorsMTOR protein, humanTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinaseProto-Oncogene Proteins c-akt
Year: 2011 PMID： 22005538 DOI： 10.1097/01.JTO.0000407566.37523.c5
Source DB: PubMed Journal: J Thorac Oncol ISSN： 1556-0864 Impact factor: 15.609